Sluggish sales revenue worries domestic new drug makers

Domestic drug manufacturers, who have rolled out a total of nine new drugs since 1999, worry about lackluster sales performance last year, industry sources said.

The sources attributed such sluggish sales revenue to local doctors' lack of confidence for Korea's new drugs, saturated market conditions, smaller market size and lack of cut-edge marketing capability on the part of domesti...